A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours

According to the neuroendocrine tumour (NET) characteristics, 3 to 7 different treatment options are available, corresponding to 6 to 5,040 theoretical different sequences. Even though each patient is unique and despite a large heterogeneity in NET characteristics, the present review aims to discuss...

Full description

Bibliographic Details
Published in:	Therapeutic Advances in Medical Oncology
Main Authors:	Marine Perrier, Jean-Yves Scoazec, Thomas Walter
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-04-01
Online Access:	https://doi.org/10.1177/17588359231171041

Similar Items

Neuroendocrine Tumour Grade 2, Well Differentiated in Distal Ileum
by: iftahillah - Alhari, et al.
Published: (2023-04-01)

Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry
by: Attila Kollar, et al.
Published: (2020-01-01)

TREATMENT OF PATIENTS WITH PANCREATIC NEUROENDOCRINE TUMOURS DEPENDING ON THE DIFFERENTIATION GRADE
by: A. Z. Isyangulova, et al.
Published: (2019-11-01)

[18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study
by: David Chan, et al.
Published: (2025-07-01)

Chronic venulectasias secondary to persistent flushing in the setting of a metastatic well-differentiated neuroendocrine tumor
by: Eleanor M. Pope, BA, et al.
Published: (2022-08-01)

Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours
by: Jan Musiałkiewicz, et al.
Published: (2025-09-01)

Metastatic pancreatic carcinoma with neuroendocrine differentiation in a cat
by: Aline Nochi Berto, et al.
Published: (2024-02-01)

Molecular imaging for neuroendocrine tumours
by: Kwadwo Antwi, et al.
Published: (2019-03-01)

Gastroenteropancreatic neuroendocrine tumours – an overview
by: Karol Maciejewski, et al.
Published: (2022-12-01)

Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
by: Vishnu Prasad, et al.
Published: (2023-05-01)

Chinese interpretation of European Neuroendocrine Tumour Society 2023 guidance for nonfunctioning pancreatic neuroendocrine tumours
by: HAN Liang, LIU Haonan, WU Zheng
Published: (2024-01-01)

The concurrent occurrence of neuroendocrine tumour and gastrointestinal stromal tumours
by: Divya Rathod, et al.
Published: (2022-10-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

WCN25-1879 LUTETIUM IN THE TREATMENT OF METASTATIC NEUROENDOCRINE TUMOUR IN A PATIENT ON MAINTENANCE HEMODIALYSIS - A CASE REPORT
by: Priyanka Bathrinarayanan, et al.
Published: (2025-02-01)

Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours
by: Mirela Gherghe, et al.
Published: (2023-01-01)

A well-differentiated neuroendocrine tumor of the left kidney
by: Hongyan Jiang, et al.
Published: (2024-12-01)

NEUROENDOCRINE TUMOURS OF THE APPENDIX IN CHILDREN AND ADOLESCENTS
by: Neža Salobir, et al.
Published: (2024-12-01)

Neuroendocrine Tumours: a Literature Review
by: K. V. Menshikov, et al.
Published: (2021-05-01)

GALLBLADDER NEUROENDOCRINE TUMOUR – AN ACCIDENTAL DISCOVERY
by: Gabriela ANGELESCU, et al.
Published: (2021-06-01)

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
by: Paweł Gut
Published: (2020-01-01)

Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies
by: Lívia Sira, et al.
Published: (2023-02-01)

Fatal Paraneoplastic Embolisms in Both Circulations in a Patient with Poorly Differentiated Neuroendocrine Tumour
by: A. Busch, et al.
Published: (2013-01-01)

Well differentiated neuroendocrine tumors, a single center experience
by: Ece Esin, et al.
Published: (2018-12-01)

Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
by: Martina Hinterleitner, et al.
Published: (2024-01-01)

The Ace of Spades: Reverse Takotsubo Cardiomyopathy in the Context of Angiographic Embolization of Recurrent Metastatic Serotonin-Positive Neuroendocrine Tumour of the Pancreas
by: Ian A. Mazzetti, et al.
Published: (2013-01-01)

Primary renal well-differentiated neuroendocrine tumor: A case report
by: Hong Fan, et al.
Published: (2024-10-01)

Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine Tumors
by: Eric Lee, et al.
Published: (2012-01-01)

Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients
by: Julie Refardt, et al.
Published: (2022-07-01)

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
by: Cristina Lamas, et al.
Published: (2023-08-01)

Influence of chemiotherapeutic protocol and neuroendocrine differentiation on metastatic non-small cell lung cancer treatment results
by: Tomić Ilija, et al.
Published: (2007-01-01)

An Unusual Location of Neuroendocrine Tumour: Primary Hepatic Origin
by: A. Bahar Ceyran, et al.
Published: (2015-01-01)

Unusual Paraneoplastic Syndrome Accompanies Neuroendocrine Tumours of the Pancreas
by: Helga Bertani, et al.
Published: (2011-01-01)

Time toxicity of lutetium 177 in gastroenteropancreatic neuroendocrine tumours
by: Marcos Daniel Bortz, et al.
Published: (2024-11-01)

Feasibility of the new WHO classification of pulmonary neuroendocrine tumours
by: AB Younossian, et al.
Published: (2002-09-01)

Detection of Neuroendocrine Tumours by Enteroscopy: A Case Report
by: Adriana Ortega Larrode, et al.
Published: (2023-08-01)

Sarcoidosis and neuroendocrine tumours: case report and literature review
by: Muhanad Taha, et al.
Published: (2021-07-01)

Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours
by: Valentina Guarnotta, et al.
Published: (2023-09-01)

Intrapancreatic accessory spleen mimicking a pancreatic neuroendocrine tumour - An important but almost forgotten differential diagnosis
by: Kaique Flavio Xavier Cardoso Filardi, et al.
Published: (2025-07-01)

Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours
by: Karolina Morawiec-Sławek, et al.
Published: (2024-11-01)

Pathogenesis, diagnosis and treatment of primary renal well-differentiated neuroendocrine tumors: a review of the literature
by: Zhongqi Zhang, et al.
Published: (2024-10-01)